197 related articles for article (PubMed ID: 16415862)
1. Alkylation of duplex DNA in nucleosome core particles by duocarmycin SA and yatakemycin.
Trzupek JD; Gottesfeld JM; Boger DL
Nat Chem Biol; 2006 Feb; 2(2):79-82. PubMed ID: 16415862
[TBL] [Abstract][Full Text] [Related]
2. DNA alkylation properties of yatakemycin.
Parrish JP; Kastrinsky DB; Wolkenberg SE; Igarashi Y; Boger DL
J Am Chem Soc; 2003 Sep; 125(36):10971-6. PubMed ID: 12952479
[TBL] [Abstract][Full Text] [Related]
3. Duocarmycins binding to DNA investigated by molecular simulation.
Spiegel K; Rothlisberger U; Carloni P
J Phys Chem B; 2006 Mar; 110(8):3647-60. PubMed ID: 16494420
[TBL] [Abstract][Full Text] [Related]
4. High resolution solution structure of a DNA duplex alkylated by the antitumor agent duocarmycin SA.
Eis PS; Smith JA; Rydzewski JM; Case DA; Boger DL; Chazin WJ
J Mol Biol; 1997 Sep; 272(2):237-52. PubMed ID: 9299351
[TBL] [Abstract][Full Text] [Related]
5. Yatakemycin: total synthesis, DNA alkylation, and biological properties.
Tichenor MS; Boger DL
Nat Prod Rep; 2008 Apr; 25(2):220-6. PubMed ID: 18389136
[TBL] [Abstract][Full Text] [Related]
6. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
Isomura M; Sugiyama H; Saito I
Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis and evaluation of iso-duocarmycin SA and iso-yatakemycin.
MacMillan KS; Nguyen T; Hwang I; Boger DL
J Am Chem Soc; 2009 Jan; 131(3):1187-94. PubMed ID: 19154178
[TBL] [Abstract][Full Text] [Related]
8. The structural basis for in situ activation of DNA alkylation by duocarmycin SA.
Smith JA; Bifulco G; Case DA; Boger DL; Gomez-Paloma L; Chazin WJ
J Mol Biol; 2000 Jul; 300(5):1195-204. PubMed ID: 10903864
[TBL] [Abstract][Full Text] [Related]
9. Nucleosome Assembly Alters the Accessibility of the Antitumor Agent Duocarmycin B2 to Duplex DNA.
Zou T; Kizaki S; Pandian GN; Sugiyama H
Chemistry; 2016 Jun; 22(26):8756-8. PubMed ID: 27123891
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional alkylating agents derived from duocarmycin SA: potent antitumor activity with altered sequence selectivity.
Boger DL; Searcey M; Tse WC; Jin Q
Bioorg Med Chem Lett; 2000 Mar; 10(5):495-8. PubMed ID: 10743956
[TBL] [Abstract][Full Text] [Related]
11. CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
Boger DL; Johnson DS
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3642-9. PubMed ID: 7731958
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer.
Tichenor MS; Trzupek JD; Kastrinsky DB; Shiga F; Hwang I; Boger DL
J Am Chem Soc; 2006 Dec; 128(49):15683-96. PubMed ID: 17147378
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysis.
Boger DL; Santillán A; Searcey M; Brunette SR; Wolkenberg SE; Hedrick MP; Jin Q
J Org Chem; 2000 Jun; 65(13):4101-11. PubMed ID: 10866627
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a duocarmycin-DNA adduct-recognizing protein in cancer cells.
Asai A; Yano K; Mizukami T; Nakano H
Cancer Res; 1999 Nov; 59(21):5417-20. PubMed ID: 10554008
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of sequence-specific DNA alkylating agents: effect of alkylation subunits.
Shimizu T; Sasaki S; Minoshima M; Shinohara K; Bando T; Sugiyama H
Nucleic Acids Symp Ser (Oxf); 2006; (50):155-6. PubMed ID: 17150864
[TBL] [Abstract][Full Text] [Related]
16. Systematic exploration of the structural features of yatakemycin impacting DNA alkylation and biological activity.
Tichenor MS; MacMillan KS; Trzupek JD; Rayl TJ; Hwang I; Boger DL
J Am Chem Soc; 2007 Sep; 129(35):10858-69. PubMed ID: 17691783
[TBL] [Abstract][Full Text] [Related]
17. DNA alkylation by minor groove-binding N1-alkoxyalkyl-bis-benzimidazoles.
Gupta R; Huang L; Wang H; Lown JW
Anticancer Drug Des; 1995 Sep; 10(6):451-61. PubMed ID: 7575987
[TBL] [Abstract][Full Text] [Related]
18. NMR structure of the (+)-CPI-indole/d(GACTAATTGAC)-d(GTCAATTAGTC) covalent complex.
Bassarello C; Cimino P; Bifulco G; Boger DL; Smith JA; Chazin WJ; Gomez-Paloma L
Chembiochem; 2003 Nov; 4(11):1188-93. PubMed ID: 14613110
[TBL] [Abstract][Full Text] [Related]
19. Getting under wraps: alkylating DNA in the nucleosome.
Gates KS
Nat Chem Biol; 2006 Feb; 2(2):64-6. PubMed ID: 16421582
[No Abstract] [Full Text] [Related]
20. Antitumor activity of sequence-specific alkylating agents: pyrolle-imidazole CBI conjugates with indole linker.
Shinohara K; Bando T; Sasaki S; Sakakibara Y; Minoshima M; Sugiyama H
Cancer Sci; 2006 Mar; 97(3):219-25. PubMed ID: 16542219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
